Literature DB >> 27459423

Endogenous Endophthalmitis in the American and Korean Population: An 8-year Retrospective Study.

Heeyoon Cho1,2, Yong Un Shin2, Nicole H Siegel3, Hyeong Gon Yu4, Lucia Sobrin1, Achal Patel3, Marlene L Durand1,5, Joan W Miller1, Deeba Husain1.   

Abstract

PURPOSE: To study the clinical features of endogenous endophthalmitis (EE) in sample patient populations from the USA and South Korea over an 8-year period.
METHODS: We reviewed data from 128 eyes of 60 American and 48 Korean patients diagnosed with EE and compared their clinical characteristics.
RESULTS: Fungemia and liver abscess were the most common extraocular infection sources among American (26.7%) and Korean patients (33.3%), respectively. Klebsiella pneumoniae and Candida species were the most common pathogens of EE in the Korean and the American patients, respectively. Endophthalmitis caused by fungi had a better visual prognosis than that caused by bacteria (p = 0.001). Vitrectomy was beneficial for eyes with EE due to virulent bacteria presenting with worse than counting finger vision.
CONCLUSIONS: The predisposing conditions and responsible organisms for EE vary in different regions of the world. The visual prognosis was strongly influenced by the underlying pathogen.

Entities:  

Keywords:  Endogenous; endophthalmitis; infectious; vitrectomy

Mesh:

Year:  2016        PMID: 27459423     DOI: 10.1080/09273948.2016.1195000

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  14 in total

1.  59 eyes with endogenous endophthalmitis- causes, outcomes and mortality in a Danish population between 2000 and 2016.

Authors:  Søren Solborg Bjerrum; Morten la Cour
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-08       Impact factor: 3.117

Review 2.  Bacterial and Fungal Endophthalmitis.

Authors:  Marlene L Durand
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Microbial spectrum and risk factors of endogenous endophthalmitis in a tertiary center of Northern China.

Authors:  Lin-Yang Gan; Jun-Jie Ye; Hui-Ying Zhou; Han-Yi Min; Lin Zheng
Journal:  Int J Ophthalmol       Date:  2022-10-18       Impact factor: 1.645

4.  Clinical characteristics of endogenous Klebsiella pneumoniae endophthalmitis: a 13-year experience.

Authors:  Ji Hwan Lee; Hee Suk Kim; Suk Ho Byeon; Sung Soo Kim; Hyoung Jun Koh; Sung Chul Lee; Christopher Seungkyu Lee
Journal:  Int Ophthalmol       Date:  2022-04-17       Impact factor: 2.029

5.  Endogenous Endophthalmitis.

Authors:  Emmett T Cunningham; Harry W Flynn; Nidhi Relhan; Manfred Zierhut
Journal:  Ocul Immunol Inflamm       Date:  2018       Impact factor: 3.070

6.  Nine-Year Analysis of Isolated Pathogens and Antibiotic Susceptibilities of Infectious Endophthalmitis from a Large Referral Eye Center in Southern China.

Authors:  Lixia Lin; Feng Mei; Jingyu Liao; Yao Yang; Fang Duan; Xiaofeng Lin
Journal:  Infect Drug Resist       Date:  2020-02-13       Impact factor: 4.003

7.  Visual outcome of endogenous endophthalmitis in Thailand.

Authors:  Preeyachan Lourthai; Pitipol Choopong; Dhanach Dhirachaikulpanich; Kunravitch Soraprajum; Warinyupa Pinitpuwadol; Noppakhun Punyayingyong; Yaninsiri Ngathaweesuk; Nattaporn Tesavibul; Sutasinee Boonsopon
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

8.  Endogenous fungal endophthalmitis in COVID-19 patients: An unexplored possibility.

Authors:  Parthopratim Dutta Majumder
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

9.  Analysis of Klebsiella as a Prognostic Factor of Ocular Outcomes in Endogenous Endophthalmitis with Decision Tree Analysis.

Authors:  Hyejin Jung; Shin Woo Kim; Hyun Ha Chang; Sang Ah Lee; Yoonjung Kim; Soyoon Hwang; Su Jeong Kim; Jong Myung Lee
Journal:  Infect Chemother       Date:  2018-09

10.  Klebsiella pneumoniae Orbital Cellulitis: Clinical Manifestations and Outcomes in a Tertiary Medical Center in Taiwan.

Authors:  Chieh-Hung Yen; Shu-Ya Wu; Yi-Lin Liao
Journal:  J Ophthalmol       Date:  2018-10-02       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.